iShares China Large-Cap ETF (FXI)

Key Updates

FXI declined 2.02% to $37.30 since the May 13 report, reversing the prior period's diplomatic optimism as the initial enthusiasm from Trump's Beijing visit dissipated. The ETF now trades 2.57% below its year-to-date starting level and 7.02% below its six-month high, reflecting persistent headwinds despite Morgan Stanley's upgraded price targets. This pullback suggests investors are taking profits following the 2.5% rally during Trump's visit, with market participants awaiting concrete policy outcomes rather than speculative positioning on diplomatic gestures.

Current Trend

FXI remains in a downtrend on a six-month basis (-7.02%) and year-to-date (-2.57%), despite brief rallies tied to diplomatic events. The ETF has demonstrated volatility around geopolitical catalysts, gaining 2.5% during Trump's visit but subsequently retracing those gains. Near-term momentum shows marginal strength over one month (+1.12%) and five days (+0.31%), but the recent 2.50% single-day decline indicates fragile sentiment. The price action suggests FXI is trading within a range-bound pattern, with resistance forming around the $38-$38.50 level established during diplomatic optimism and support near current levels around $37.

Investment Thesis

The investment thesis centers on China's structural positioning in AI value chains, green energy transition, and semiconductor localization, supported by government policy alignment and competitive cost advantages. Morgan Stanley's upgraded targets project 8-12% upside through 2Q 2027, driven by improved earnings visibility, yuan appreciation, and China's dominance in upstream supply chains. The AI sector presents particular opportunity, with Chinese AI models achieving $1-1.75 billion in revenue potential for 2026 and passive inflows of $1.25-1.75 billion expected from Hang Seng Tech Index inclusions on June 8. However, the thesis faces headwinds from concentration risk in Hong Kong-listed large caps, margin pressures in e-commerce and advertising sectors, and the structural underperformance of Hong Kong Tech stocks versus mainland ChiNext peers. The investment case requires distinguishing between hardware/battery manufacturers with clear earnings visibility and internet platforms facing competitive pressures.

Thesis Status

The thesis remains intact but faces near-term execution risk. Morgan Stanley's bullish outlook and AI sector catalysts provide fundamental support, yet FXI's composition skews toward Hong Kong-listed large caps that have underperformed mainland hardware plays. The 2.02% decline following Trump's visit demonstrates that diplomatic optimism alone cannot sustain rallies without concrete trade agreements or policy changes. The upcoming June 8 AI stock inclusions and Trump-Xi summit outcomes represent critical near-term catalysts that will validate or challenge the thesis. Current positioning suggests the market is adopting a "wait-and-see" approach, with the -2.57% YTD performance reflecting skepticism about whether structural advantages can offset cyclical headwinds in consumer-facing segments. The thesis requires confirmation through actual earnings improvements and tangible policy developments rather than speculative positioning.

Key Drivers

Trump's Beijing visit generated initial optimism but failed to produce lasting momentum, with FXI gaining 2.5% during the visit before retracing. Morgan Stanley's upgraded price targets project 8-12% upside through 2Q 2027, citing improved earnings, supply chain positioning, and yuan appreciation. The June 8 inclusion of Knowledge Atlas Technology and MiniMax in the Hang Seng Tech Index is expected to drive $1.25-1.75 billion in passive inflows. However, structural divergence persists between ChiNext (up nearly 100% over one year) and Hang Seng Tech (down 4%), reflecting investor preference for hardware manufacturers over internet platforms. The upcoming Trump-Xi summit represents a key catalyst for potential trade relaxations, though concrete outcomes remain uncertain.

Technical Analysis

FXI is trading at $37.30, having established resistance around $38.08 during the Trump visit rally and now testing support near current levels. The 2.50% single-day decline signals profit-taking after the diplomatic-driven rally, with the ETF forming a lower high pattern relative to previous recovery attempts. Volume patterns during the recent decline suggest distribution rather than capitulation. Key resistance levels are $38.00-$38.50 (May highs) and $40.00 (psychological level), while support sits at $37.00 (current area) and $36.44 (April 23 low). The 6-month downtrend (-7.02%) remains dominant, with near-term oscillations creating a range-bound environment. A break above $38.50 would signal renewed momentum, while a move below $36.44 would confirm continued weakness. The technical picture suggests consolidation within the $36.50-$38.50 range pending fundamental catalysts.

Bull Case

• Morgan Stanley projects 8-12% upside through 2Q 2027 across Chinese indexes, driven by improved earnings, supply chain positioning, and yuan appreciation against the dollar, providing institutional validation for the recovery thesis with specific price targets including MSCI China at 91.
• Passive inflows of $1.25-1.75 billion expected from June 8 Hang Seng Tech Index inclusions of AI companies Knowledge Atlas and MiniMax, with frontier Chinese AI models projected to achieve $1 billion in revenue for 2026, potentially doubling in 2027.
• ChinaAMC's China Opportunities Fund delivered 15% YTD returns, outperforming 98% of peers, demonstrating that selective positioning in AI value chains and healthcare can generate alpha despite broader market weakness, with Chinese AI development costs significantly lower than US counterparts.
• Trump's Beijing visit sparked bullish positioning in China-related equities, with potential for trade relaxations and diplomatic progress creating upside scenarios if concrete policy agreements materialize from ongoing high-level discussions.
• China's competitive advantages in semiconductor localization, AI, and biotech development are supported by government policy alignment with the 15th Five-Year Plan, positioning technology stocks with strong innovation capabilities and green energy companies for structural growth regardless of near-term volatility.

Bear Case

• Hong Kong's Hang Seng Tech Index declined 4% over the past year while ChiNext nearly doubled, with FXI's large-cap Hong Kong composition exposing investors to underperforming internet platforms like Alibaba and Baidu facing margin pressures from e-commerce price wars and advertising competition, where consensus forward earnings estimates fell 26% from July peaks.
• Major China-focused ETFs remain significantly below October highs, with FXI down 11%, MCHI down 13.6%, and KWEB down 33%, indicating sustained selling pressure and investor skepticism about Chinese equities despite periodic rallies tied to diplomatic events.
• The 2.5% rally during Trump's visit has reversed, demonstrating that diplomatic optimism without concrete trade agreements or policy changes cannot sustain momentum, with the market requiring tangible outcomes rather than speculative positioning on geopolitical developments.
• Concentration risk in ChiNext's top seven members comprising 55% of the index highlights vulnerability to sector-specific downturns, while FXI's large-cap composition similarly concentrates exposure to a limited number of Hong Kong-listed companies facing structural headwinds in consumer-facing segments.
• Alibaba declined 30% from its October peak despite Trump's China trip, with the company missing earnings expectations even as shares rallied 8% on diplomatic optimism, illustrating that fundamental challenges in e-commerce profitability persist regardless of macroeconomic or geopolitical catalysts affecting sentiment.